Prenatal Cadmium Exposure and Maternal Sex Steroid Hormone Concentrations across Pregnancy
- PMID: 37505555
- PMCID: PMC10384739
- DOI: 10.3390/toxics11070589
Prenatal Cadmium Exposure and Maternal Sex Steroid Hormone Concentrations across Pregnancy
Abstract
Cadmium exposure has been associated with adverse perinatal outcomes. One possible mechanism is endocrine disruption. Studies of non-pregnant adults suggest that cadmium impacts androgen production; here, we examined these associations during pregnancy. Participants in the Understanding Pregnancy Signals and Infant Development (UPSIDE) cohort provided biospecimens and questionnaire data in each trimester (n = 272). We quantified urinary cadmium, serum total testosterone (TT), estrone, estradiol, and estriol and serum free testosterone (fT). In adjusted longitudinal models, we examined sex steroid concentrations across pregnancy in relation to specific gravity-adjusted, ln-transformed cadmium concentrations. Additionally, we examined trimester-specific associations and stratified models by fetal sex. Results are presented as percent change (%∆) in hormone concentrations. In longitudinal models, higher cadmium concentrations were associated with lower fT across pregnancy (%∆ = -5.19, 95%CI: -8.33, -1.93), with no differences in other hormones observed. In trimester-specific models, higher cadmium concentrations were associated with lower TT in trimester 2 (%∆ = -15.26, 95%CI: -25.15, -4.06) and lower fT in trimester 3 (%∆ = -14.35, 95%CI: -19.75, -8.59). Associations with TT were stronger in pregnancies carrying female fetuses. Maternal cadmium exposure may be associated with reduced testosterone in pregnancy. Additional work is necessary to understand how alterations in gestational testosterone activity may impact pregnancy and child health.
Keywords: androgens; cadmium; pregnancy; sex steroid hormones; testosterone.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Associations between neighborhood stress and maternal sex steroid hormones in pregnancy.BMC Pregnancy Childbirth. 2023 Oct 16;23(1):730. doi: 10.1186/s12884-023-06043-0. BMC Pregnancy Childbirth. 2023. PMID: 37845614 Free PMC article.
-
Maternal organophosphate esters and sex steroid hormones in mid-pregnancy.Environ Res. 2025 Apr 15;271:121063. doi: 10.1016/j.envres.2025.121063. Epub 2025 Feb 6. Environ Res. 2025. PMID: 39922261
-
Associations between mycoestrogen exposure and sex steroid hormone concentrations in maternal serum and cord blood in the UPSIDE pregnancy cohort.Int J Hyg Environ Health. 2024 Jul;260:114405. doi: 10.1016/j.ijheh.2024.114405. Epub 2024 Jun 14. Int J Hyg Environ Health. 2024. PMID: 38878407 Free PMC article.
-
Predictors of Steroid Hormone Concentrations in Early Pregnancy: Results from a Multi-Center Cohort.Matern Child Health J. 2019 Mar;23(3):397-407. doi: 10.1007/s10995-018-02705-0. Matern Child Health J. 2019. PMID: 30659461 Free PMC article.
-
Obstetrical complications associated with abnormal maternal serum markers analytes.J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5. J Obstet Gynaecol Can. 2008. PMID: 19038077 Review. English, French.
References
-
- Faroon O., Ashizawa A., Wright S., Tucker P., Jenkins K., Ingerman L., Rudisill C. Toxicological Profile for Cadmium. Department of Health and Human Services, Public Health Service; Gosford, Australia: 2012. Agency for Toxic Substances and Disease Registry (ATSDR) - PubMed
-
- Watson C.V., Lewin M., Ragin-Wilson A., Jones R., Jarrett J.M., Wallon K., Ward C., Hilliard N., Irvin-Barnwell E. Characterization of trace elements exposure in pregnant women in the United States, NHANES 1999–2016. Environ. Res. 2020;183:109208. doi: 10.1016/j.envres.2020.109208. - DOI - PMC - PubMed
Grants and funding
- UH3OD023349/NH/NIH HHS/United States
- UL1TR003017/NH/NIH HHS/United States
- T32 ES007148/ES/NIEHS NIH HHS/United States
- F31ES032319/NH/NIH HHS/United States
- P30 ES005022/ES/NIEHS NIH HHS/United States
- T32ES007148/NH/NIH HHS/United States
- R01 ES029275/ES/NIEHS NIH HHS/United States
- P30ES005022/NH/NIH HHS/United States
- UG3 OD023349/OD/NIH HHS/United States
- R01ES029275/NH/NIH HHS/United States
- R01 HD083369/HD/NICHD NIH HHS/United States
- UL1 TR003017/TR/NCATS NIH HHS/United States
- R01HD083369/NH/NIH HHS/United States
- F31 ES032319/ES/NIEHS NIH HHS/United States
- UG3OD023349/NH/NIH HHS/United States
- UH3 OD023349/OD/NIH HHS/United States
LinkOut - more resources
Full Text Sources